Article Figures & Data
Tables
- Table 1.
Association of PGR polymorphism +331G/A with endometrial cancer risk: odds ratio (95% confidence interval)
Cases Controls Crude Adjusted for age Noncarriers of +331A allele 255 289 1.00 1.00 Carriers of +331A allele 20 25 0.91 (0.49-1.67) 1.04 (0.56-1.93) - Table 2.
Interaction between PGR polymorphism +331G/A and risk factors for endometrial cancer: odds ratio (95% confidence interval) for endometrial cancer risk
Noncarriers of +331A allele Carriers of +331A allele Pinteraction BMI < 25 1.00 1.33 (0.46-3.90) 25 ≤ BMI ≤ 28 1.20 (0.76-1.91) 1.67 (0.49-5.66) BMI > 28 2.27 (1.48-3.47) 1.11 (0.36-3.45) 0.35 Non-HRT users 1.00 1.03 (0.42-2.55) HRT users 1.79 (1.25-2.57) 1.81 (0.76-4.33) 0.96 Abbreviations: BMI, body mass index; HRT, hormone replacement therapy.
July 2006
Volume 15, Issue 7
Volume 15, Issue 7
No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer
Jump to section
Advertisement